EOLS Logo

Evolus, Inc. (EOLS) 

NASDAQ$13.2
Market Cap
$839.35M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
578 of 924
Rank in Industry
35 of 56

EOLS Insider Trading Activity

EOLS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$9,230,32520100

Related Transactions

Yamagishi-Dressler TomokoChief Marketing Officer0$01$89,251$-89,251
GILL DAVID Ndirector0$02$131,010$-131,010
Parschauer Karah Herdmandirector0$01$167,465$-167,465
Beaver SandraChief Financial Officer0$04$176,078$-176,078
Avelar RuiSee Remarks0$03$452,549$-452,549
Malik Vikramdirector0$02$459,215$-459,215
MOATAZEDI DAVIDSee Remarks0$07$7.75M$-7.75M

About Evolus, Inc.

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Insider Activity of Evolus, Inc.

Over the last 12 months, insiders at Evolus, Inc. have bought $0 and sold $9.23M worth of Evolus, Inc. stock.

On average, over the past 5 years, insiders at Evolus, Inc. have bought $3.4M and sold $18.29M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 174,967 shares for transaction amount of $1.3M was made by Malik Vikram (director) on 2023‑08‑15.

List of Insider Buy and Sell Transactions, Evolus, Inc.

2025-03-12SaleParschauer Karah Herdmandirector
12,888
0.0196%
$12.99$167,465-2.53%
2024-12-23SaleMOATAZEDI DAVIDSee Remarks
10,502
0.0167%
$10.85$113,967+24.08%
2024-12-23SaleAvelar RuiSee Remarks
2,252
0.0036%
$10.85$24,438+24.08%
2024-12-23SaleBeaver SandraChief Financial Officer
1,586
0.0025%
$10.85$17,211+24.08%
2024-09-06SaleBeaver SandraChief Financial Officer
3,276
0.0053%
$14.98$49,074-4.69%
2024-08-30SaleYamagishi-Dressler TomokoChief Marketing Officer
5,631
0.0089%
$15.85$89,251-11.39%
2024-06-06SaleMOATAZEDI DAVIDSee Remarks
175,940
0.2852%
$12.59$2.21M+8.19%
2024-06-05SaleMOATAZEDI DAVIDSee Remarks
155,278
0.2465%
$12.92$2.01M+3.15%
2024-06-04SaleMOATAZEDI DAVIDSee Remarks
140,214
0.2217%
$12.73$1.78M+3.89%
2024-06-03SaleMalik Vikramdirector
7,500
0.0119%
$12.96$97,203+2.31%
2024-05-14SaleGILL DAVID Ndirector
6,718
0.0106%
$12.60$84,654+3.11%
2024-05-13SaleMalik Vikramdirector
28,000
0.0459%
$12.93$362,012+4.36%
2024-05-13SaleGILL DAVID Ndirector
3,643
0.0059%
$12.72$46,356+4.36%
2024-05-10SaleMOATAZEDI DAVIDSee Remarks
16,051
0.0256%
$12.72$204,127+3.06%
2024-05-10SaleAvelar RuiSee Remarks
3,441
0.0055%
$12.72$43,761+3.06%
2024-05-10SaleBeaver SandraChief Financial Officer
2,423
0.0039%
$12.72$30,814+3.06%
2024-03-27SaleMOATAZEDI DAVIDSee Remarks
6,236
0.01%
$13.86$86,431-6.36%
2024-03-19SaleMOATAZEDI DAVIDSee Remarks
96,566
0.1564%
$13.92$1.34M-5.87%
2024-03-19SaleAvelar RuiSee Remarks
27,603
0.0447%
$13.92$384,350-5.87%
2024-03-19SaleBeaver SandraChief Financial Officer
5,672
0.0092%
$13.92$78,978-5.87%
Total: 116
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Malik Vikramdirector
246514
0.3877%
$3.25M47+1.4%
GILL DAVID Ndirector
33964
0.0534%
$448,324.8023+8.2%
Medytox Inc.
3381326
5.3177%
$44.63M159<0.0001%
Jafar Michael M.See Remarks
174851
0.275%
$2.31M11<0.0001%
BLANK SIMONE
54881
0.0863%
$724,429.2030<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$910,099,463
123
11.52%
$2.63B
$187,390,806
89
12.63%
$777.44M
$12,681,496
70
20.90%
$804.92M
$14,599,168
59
12.79%
$1.36B
$129,489,279
57
26.09%
$635.41M

EOLS Institutional Investors: Active Positions

Increased Positions82+44.32%6M+12.88%
Decreased Positions75-40.54%5M-9.54%
New Positions26New2MNew
Sold Out Positions27Sold Out999,404Sold Out
Total Postitions192+3.78%52M+3.35%

EOLS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Perceptive Advisors Llc$75,078.008.17%5.15M-210,776-3.94%2024-12-31
Tang Capital Management Llc$72,912.007.93%5M+150,000+3.09%2024-12-31
Blackrock, Inc.$63,684.006.93%4.36M+134,747+3.19%2024-12-31
Vanguard Group Inc$46,271.005.03%3.17M-23,927-0.75%2024-12-31
Nantahala Capital Management, Llc$45,669.004.97%3.13M+305,300+10.81%2024-12-31
Caligan Partners Lp$39,282.004.27%2.69M+498,900+22.75%2024-12-31
State Street Corp$20,752.002.26%1.42M+144,528+11.31%2024-12-31
Millennium Management Llc$19,965.002.17%1.37M+338,753+32.9%2024-12-31
Boothbay Fund Management, Llc$18,789.002.04%1.29M+304,065+30.91%2024-12-31
Stonepine Capital Management, Llc$18,451.002.01%1.26M-105,170-7.68%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
1.43SellsBuysStrong BuyBuyHoldSellStrong SellEOLSHighAverageLowSeries 4